Reported 1 day ago
A recent JPMorgan survey indicates that less than 50% of employers offer coverage for GLP-1 weight-loss medications, despite increased overall coverage for diabetes drugs. While 80% of companies cover diabetes treatments, only 45% extend that coverage to weight loss. The rising demand for these drugs raises concerns over costs, as nearly 50 million adults in employer plans qualify for treatment. The future of coverage remains uncertain, with only 13% of non-covering employers planning to include weight-loss medications.
Source: YAHOO